The novel severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) emerged in
China in December 2019 1 and was declared a pandemic by the World Health Organization …

BACKGROUND Despite efforts to mitigate the impact of dengue virus (DENV) epidemics, the
virus remains a public health problem in tropical and subtropical regions around the world. …

… The effectiveness of preventive therapy was 63% (adjusted HR 0·37 [95% CI 0·30–0·47])
among all exposed children, and 91% (adjusted HR 0·09 [0·05–0·15]) among those with a …

… [HR = 0.50 (95% CI 0.35–0.71)], especially if this therapy was introduced during the first 4
days of admission to the ICU [HR = … factors were adjusted for [HR 0.55 (95% CI 0.31–0.98)]. …

Over 400 million people are estimated to be at risk of acquiring dengue virus (DENV).
Despite efforts to mitigate the impact of DENV epidemics, the virus remains a public health …

… We found that Xpert-MTB-HR outperformed CRP, but neither met the World Health
Organization's target product profile benchmarks for accuracy (70% specificity at 90% sensitivity). …

São Paulo is a state in Brazil with one of the highest numbers of confirmed and severe cases
of coronavirus disease (COVID-19), with an incidence of 294 hospitalizations per 100,000 …

… Experiments were conducted using male Wistar rats (250–350 g), maintained on a 12-hour
light/12-hour dark cycle in a room kept at a constant temperature of 22 ± 1C, controlled …

Background Tuberculosis (TB) is a major cause of morbidity and mortality among incarcerated
populations globally. We performed mass TB screening in 3 prisons and assessed yield, …

… The association between CCeo and polymyxin B showed a decrease in terms of viable cell
counts on survival curves over time after a 4 hour-treatment with a FIC index value of 0.006. …